Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 82, Issue 5, 2006, Pages 1815-1820

  Nwogu, Chumy ^a   Fischer, Gabor ^b   Tan, DongFeng ^b   Glinianski, Michal ^a   Lamonica, Dominick ^a   Demmy, Todd ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; FLUORODEOXYGLUCOSE F 18; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; DEVICE; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MEDIASTINOSCOPY; MICROMETASTASIS; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAINING; SURGICAL TECHNIQUE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THORAX;

EID: 33750056685     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.05.104     Document Type: Article

References (23)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Chen Z.L., Perez S., Holmes E.C., et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 85 (1993) 493-498
3. Faries M.B., Bleicher R.J., Ye X., Essner R., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms. Arch Surg 139 (2004) 870-876
4. Gu C.D., Osaki T., Oyama T., et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Ann Surg 235 (2002) 133-139
5. Jiao X., and Krasna M.J. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 74 (2002) 278-284
6. Goldstein N.S., Mani A., Chmielewski G., Welsh R., and Pursel S. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas. Am J Surg Pathol 24 (2000) 274-279
7. Liptay M.J., Grondin S.C., Fry W.A., et al. Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. J Clin Oncol 20 (2002) 1984-1988
8. Kelloff G.J., Hoffman J.M., Johnson B., et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 11 (2005) 2785-2808
9. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
10. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
11. Mavi A., Lakhani P., Zhuang H., Gupta N.C., and Alavi A. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. Radiol Clin North Am 43 (2005) 1-21 ix
12. Sachs S., and Bilfinger T.V. The impact of positron emission tomography on clinical decision making in a university-based multidisciplinary lung cancer practice. Chest 128 (2005) 698-703
13. Essner R., Daghighian F., and Giuliano A.E. Advances in FDG PET probes in surgical oncology. Cancer J 8 (2002) 100-108
14. Tiffet O., Nicholson A.G., Khaddage A., et al. Feasibility of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radio isotopic and blue dye techniques. Chest 127 (2005) 443-448
15. Minamiya Y., and Ogawa J. The current status of sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Cardiovasc Surg 11 (2005) 67-72
16. Rosell R., Gomez-Codina J., Camps C., et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26 (1999) 7-14
17. Roth J.A., Atkinson E.N., Fossella F., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
18. Ito M., Minamiya Y., Kawai H., et al. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer. J Thorac Cardiovasc Surg 130 (2005) 753-758
19. Raja S., Luketich J.D., Kelly L.A., Gooding W.E., Finkelstein S.D., and Godfrey T.E. Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg 123 (2002) 475-483
20. Richter T., Nahrig J., Komminoth P., Kowolik J., and Werner M. Protocol for ultrarapid immunostaining of frozen sections. J Clin Pathol 52 (1999) 461-463
21. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., and Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
22. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597
23. Strauss G.M., Herndon J., Maddaus M.A., et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633. J Clin Oncol 22 14 Suppl (2004) 7019 (Meeting Abstracts)